Form D · Pharmaceuticals

GALECTIN THERAPEUTICS INC

Norcross, GA · CIK 0001133416

Offering snapshot reported Jan 6, 2017 · SEC filing

Reported sold
$3M
Offering amount: $10M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 22, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 6, 2017Initial$3,000,000No comparison5SEC filing
Sep 28, 2016Initial$1,500,000No comparison1SEC filing
Dec 21, 2015Initial$0No comparison6SEC filing
Jan 12, 2011Initial$2,250,000No comparison22SEC filing
Mar 5, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Oct 30, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-277867

Source: Form D, filed Jan 6, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gilbert F Amelio Director
Jack W Callicutt Executive
James C Czirr Director
Maureen Foley Executive
Kevin D Freeman Director
Arthur R Greenberg Director
Anatole Klyosov Executive
Rod D. Martin Director
John G. Mauldin Director
S. Colin Neill Director
Gilbert S Omenn Director
Steven G. Prelack Director
Jerald Rome Director
Marc G. Rubin Director
Harold H. Shlevin Executive
Anthony D. Squeglia Executive
Peter G Traber Director, Executive
Eliezer Zomer Executive
Theodore D. Zucconi Director, Executive
Theodore Zuconni Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4960 Peachtree Industrial Boulevard Suite 240
Norcross, GA, 30071